Protara Therapeutics (TARA) Other Operating Expenses (2019 - 2022)

Protara Therapeutics (TARA) has 4 years of Other Operating Expenses data on file, last reported at $29.5 million in Q4 2022.

• On a quarterly basis, Other Operating Expenses rose 44.66% year-over-year to $29.5 million in Q4 2022; TTM through Sep 2023 was $29.5 million, a 44.66% increase from a year earlier, with the FY2022 full-year figure at $29.5 million, up 44.66% from the prior year.
• Other Operating Expenses for Q4 2022 stood at $29.5 million, up from $20.4 million in the prior quarter.
• Over the last five years, Other Operating Expenses for TARA reached as high as $29.5 million in Q4 2022 and fell as low as -$2.9 million in Q4 2019.
• Historically, Other Operating Expenses has averaged $14.7 million across 4 years, with a median of $16.1 million in 2020.
• Across the five-year window, Other Operating Expenses surged 505.97% in 2020 and soared 44.66% in 2022, its largest moves.
• Year by year, Other Operating Expenses stood at -$2.9 million in 2019, then jumped by 505.97% to $11.8 million in 2020, then jumped by 73.31% to $20.4 million in 2021, then soared by 44.66% to $29.5 million in 2022.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $29.5 million in Q4 2022, $20.4 million in Q4 2021, and $11.8 million in Q4 2020.